Baxter and Cerus launch Intercept in Portugal and Italy
This article was originally published in Clinica
Executive Summary
Blood centres in Portugal and Italy are the first sites to adopt a new blood-safety system developed by Baxter International and Cerus Corporation. The Intercept Blood System, installed at the Centro Regional de Sangue in Lisbon, Portugal, and a transfusion centre in Palermo, Italy, targets certain pathogens associated with transfusion-transmitted diseases, particularly in patients undergoing chemotherapy, heart bypass surgery and other procedures that require platelet transfusions.